Metabolic profiling reveals PAFAH1B3 as a critical driver of breast cancer pathogenicity.
about
GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and PathogenicityActivity-Based Protein Profiling of Oncogene-Driven Changes in Metabolism Reveals Broad Dysregulation of PAFAH1B2 and 1B3 in Cancer.Chemical genetics screening reveals KIAA1363 as a cytokine-lowering target.Selective inhibitor of platelet-activating factor acetylhydrolases 1b2 and 1b3 that impairs cancer cell survival.Discovery of Inhibitors for the Ether Lipid-Generating Enzyme AGPS as Anti-Cancer Agents.Systematic Identification and Assessment of Therapeutic Targets for Breast Cancer Based on Genome-Wide RNA Interference TranscriptomesDelineation of autoantibody repertoire through differential proteogenomics in hepatitis C virus-induced cryoglobulinemia.Methylglyoxal, a glycolysis side-product, induces Hsp90 glycation and YAP-mediated tumor growth and metastasis.Lipid disequilibrium disrupts ER proteostasis by impairing ERAD substrate glycan trimming and dislocation.Target identification and lead discovery by functional lipidomics.Tracking hippo in the cancer jungle.
P2860
Q28275543-C28614C8-EB83-4B9A-8444-B07F3878F980Q30299995-68A02B40-9C5B-406E-9009-2B96D75C9827Q34756802-6D2256C5-795D-48C1-BD45-4A8E2984B430Q35472210-6802ECB8-30D9-489F-850B-B99A77B839C3Q35760232-89B0F3DC-A44B-483A-9D49-FB37699880A1Q36293047-B7A9AE99-CD8A-4F86-A927-543D3F8E4490Q37086915-12F5E25F-DF36-4C7F-A5C8-AAD5F32016AEQ37368367-5432E67C-DF9B-47D1-8804-0025E3D08F95Q37583253-7CAC2D0F-DB42-42B3-9CF3-32D76BF7BD1EQ38795288-3C2F7C25-E5A8-41D6-A85F-C860036B3E7FQ50612998-56C296CF-0223-4AA3-AB67-069CA3E128B4
P2860
Metabolic profiling reveals PAFAH1B3 as a critical driver of breast cancer pathogenicity.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Metabolic profiling reveals PAFAH1B3 as a critical driver of breast cancer pathogenicity.
@ast
Metabolic profiling reveals PAFAH1B3 as a critical driver of breast cancer pathogenicity.
@en
type
label
Metabolic profiling reveals PAFAH1B3 as a critical driver of breast cancer pathogenicity.
@ast
Metabolic profiling reveals PAFAH1B3 as a critical driver of breast cancer pathogenicity.
@en
prefLabel
Metabolic profiling reveals PAFAH1B3 as a critical driver of breast cancer pathogenicity.
@ast
Metabolic profiling reveals PAFAH1B3 as a critical driver of breast cancer pathogenicity.
@en
P2093
P2860
P1476
Metabolic profiling reveals PAFAH1B3 as a critical driver of breast cancer pathogenicity
@en
P2093
Alice Shieh
Daniel I Benjamin
Daniel K Nomura
Erwan Le Scolan
Kunxin Luo
McKenna Green
Melinda M Mulvihill
Sharon M Louie
Tara Narasimhalu
Xiaodan Ji
P2860
P304
P356
10.1016/J.CHEMBIOL.2014.05.008
P577
2014-06-19T00:00:00Z